Joel Greenblatt Sage Therapeutics, Inc. Transaction History

Gotham Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $1.4 Million - $2 Million	-34,832 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $622,119 - $898,831	11,336 Added 48.25%	34,832 $1.98 Million
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $1.66 Million - $2.27 Million	23,496 New	23,496 $1.76 Million

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.